Dr. Martens Shares Rise After U.S. Sales Beat, Backed Guidance

By MarketWatch   |   1 year ago
Dr. Martens Shares Rise After U.S. Sales Beat, Backed Guidance

Dr. Martens saw a 13% stock rally after a positive first half and maintained guidance for fiscal 2025. Despite a 25% drop in 2024, the brand is optimistic about new products and direct-to-consumer sales growth.

Read More

Did you find this insightful?